Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 06/1/12 → 07/27/24 |
Funding
- Quintiles Incorporated: $371,667.00
Genentech: A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study to Evaluate The Efficacy and Safety of Ocrelizumab in Comparison to Interferon Beta-la (Rebif)
- Coyle, Patricia (PI)
- Krupp, Lauren (PI)
- Melville, Patricia (CoPI)
Project: Research